What is the Return on Assets (ROA) of TELA Bio this year?
The Return on Assets (ROA) of TELA Bio is -0.6 undefined this year.
TELA Bio ROA 2024
TELA Bio ROA
-0.6
Ticker
TELA
ISIN
US8723811084
WKN
A2PUP9
In 2024, TELA Bio's return on assets (ROA) was -0.6, a -8.41% increase from the -0.65 ROA in the previous year.
TELA Bio Aktienanalyse
What does TELA Bio do?
TELA Bio Inc is an American medical technology company that specializes in the development and manufacture of innovative surgical implants. The history of this company began in 2012 when a group of experienced bioengineers and medical professionals decided to develop a better surgical tissue replacement material. The idea was to create a product that not only supports the healing process but is also safe, durable, and easy to handle. Over the years, TELA Bio has successfully implemented the business model of complete vertical integration, which means that the company takes care of everything from research and development to production, distribution, and marketing of its products. This allows the company to build closer relationships with its customers and improve the quality of its products by addressing the needs and requirements of its users. The core business of TELA Bio focuses on a wide range of surgical tissue replacement materials specifically designed for plastic and reconstructive surgery, hernia repair, and wound healing. These products are characterized by their high biocompatibility, strength, and flexibility, and provide a safe and effective solution for a variety of medical applications. Key products offered by TELA Bio include the OviTex® product family, which includes surgical mesh materials for supporting wound healing in hernia repairs and abdominal surgeries, as well as tissue replacement materials for breast reconstruction after mastectomy. These products are known for their high biocompatibility and ability to integrate into the surrounding tissue and restore natural tissue structures. In addition, TELA Bio also offers the TELADERM®-DH product, specifically developed for wound healing in diabetes patients. This product consists of a tissue replacement material that supports skin repair and reduces the risk of infection, particularly in patients with poorly healing wounds. Overall, TELA Bio has developed a wide range of products tailored to the needs of modern medicine. The company is focused on improving the quality of medical care and providing innovative solutions for surgical wound healing. With its successful implementations in research, production, and distribution, TELA Bio is well-positioned to continue growing and solidify its position as a leading provider of medical implants. TELA Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding TELA Bio's Return on Assets (ROA)
TELA Bio's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing TELA Bio's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider TELA Bio's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in TELA Bio’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about TELA Bio stock
What was the ROA of TELA Bio compared to the previous year?
The ROA of TELA Bio has increased by -8.41% compared to the previous year.
What consequences do high ROA have for investors of TELA Bio?
A high ROA is advantageous for investors of TELA Bio, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in TELA Bio?
A low ROA can be unfavorable for investors of TELA Bio as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of TELA Bio affect the company?
An increase in ROA of TELA Bio can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of TELA Bio impact the company?
A reduction in the ROA of TELA Bio can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of TELA Bio?
Some factors that can influence the ROA of TELA Bio include revenue, operating costs, asset structure, and industry average.
Why is the ROA of TELA Bio important for investors?
The ROA of TELA Bio is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can TELA Bio take to improve ROA?
To improve ROA, TELA Bio can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does TELA Bio pay?
Over the past 12 months, TELA Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TELA Bio is expected to pay a dividend of 0 USD.
What is the dividend yield of TELA Bio?
The current dividend yield of TELA Bio is .
When does TELA Bio pay dividends?
TELA Bio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of TELA Bio?
TELA Bio paid dividends every year for the past 0 years.
What is the dividend of TELA Bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is TELA Bio located?
TELA Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von TELA Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of TELA Bio from 11/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.
When did TELA Bio pay the last dividend?
The last dividend was paid out on 11/19/2024.
What was the dividend of TELA Bio in the year 2023?
In the year 2023, TELA Bio distributed 0 USD as dividends.
In which currency does TELA Bio pay out the dividend?
The dividends of TELA Bio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von TELA Bio
Our stock analysis for TELA Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TELA Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
